Press Releases Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

End-of-day quote NEO Exchange Other stock markets 06:00:00 2023-10-05 pm EDT			5-day change	1st Jan Change
0.175 ^CAD	+45.83%		+29.63%	-61.11%

Feb. 23	Mydecine Innovations Closes Partial Debt Settlement	MT
Feb. 02	Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order	Apr. 25	AQ
Mydecine Innovations Group Inc. Announces Share for Debt Settlement	Mar. 20	AQ
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	Feb. 07	GL
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	Feb. 07	AQ
Mydecine Innovations Group Announces Director Resignation	Feb. 02	GL
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound	Dec. 18	GL
Mydecine Announces Update Regarding the Special Access Program	Nov. 28	GL
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	23-10-31	GL
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	23-10-31	AQ
Mydecine Provides Q4 2023 Business Update	23-10-26	GL
Mydecine Provides Q4 2023 Business Update	23-10-26	AQ
Mydecine Innovations Group gearing up for human trials after completing Aquis listing	23-10-18	AQ
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK	23-10-12	GL
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK	23-10-12	AQ
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings	23-10-10	AQ
Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO	23-10-05	AQ
Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date	23-09-27	AQ
Mydecine Innovations Announces Amended Press Release Relating to the Closing of Prospectus Supplement Financing	23-09-20	AQ
Mydecine Innovations Announces Closing of Prospectus Supplement Financing	23-09-19	AQ
Mydecine Innovations Group Files Prospectus Supplement	23-09-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

Press Releases

Filters